Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
O275306-1mg | 1mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $206.90 | |
O275306-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $687.90 |
Potent, selective GPR55 agonist
Synonyms | O-1602|317321-41-8|O 1602|5-METHYL-4-[(1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL]-1,3-BENZENEDIOL|5-methyl-4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]benzene-1,3-diol|CHEMBL3402654|O1602|59F4R2N5N5|5-Methyl-4-((1R,6R)-3-methyl-6-(1 |
---|---|
Specifications & Purity | 98%,10mg/ml in methyl acetate |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of GPR18;Agonist of GPR55 |
Product Description | Store at -20°C (desiccating conditions). |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 5-methyl-4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]benzene-1,3-diol |
---|---|
INCHI | InChI=1S/C17H22O2/c1-10(2)14-6-5-11(3)7-15(14)17-12(4)8-13(18)9-16(17)19/h7-9,14-15,18-19H,1,5-6H2,2-4H3/t14-,15+/m0/s1 |
InChi Key | KDZOUSULXZNDJH-LSDHHAIUSA-N |
Canonical SMILES | CC1=CC(C(CC1)C(=C)C)C2=C(C=C(C=C2C)O)O |
Isomeric SMILES | CC1=C[C@H]([C@@H](CC1)C(=C)C)C2=C(C=C(C=C2C)O)O |
PubChem CID | 45073499 |
Molecular Weight | 258.36 |
CAS Registry No. | 317321-41-8 |
---|---|
PubChem CID | 45073499 |
Wikipedia | O-1602 |
RCSB PDB Ligand | HVJ |
GPCRdb Ligand | O-1602 |
Enter Lot Number to search for COA:
Solubility | Supplied in methyl acetate (10 mg/ml) |
---|
1. Adinolfi B et al.. (2013) Anticancer activity of anandamide in human cutaneous melanoma cells.. Eur J Pharmacol, 718 (1-3): (154-9). [PMID:24041928] |